Seroprevalence of antibody to mumps virus in the US population, 1999-2004

Journal of Infectious Diseases

Volumn 202, Issue 5, 2010, Pages 667-674

  Kutty, Preeta K ^a   Kruszon Moran, Deanna M ^b   Dayan, Gustavo H ^a,c   Alexander, James P ^b   Williams, Nobia J ^a   Garcia, Philip E ^a   Hickman, Carole J ^a   McQuillan, Geraldine M ^b   Bellini, William J ^a  

^a Division of Viral Diseases   (Denmark)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ARTICLE; CHILD; EDUCATION; ETHNICITY; FEMALE; GENDER; HERD IMMUNITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUMPS; MUMPS VIRUS; POPULATION RESEARCH; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE; SEROPREVALENCE; UNITED STATES; VIRUS IMMUNITY;

ADOLESCENT; ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; AGE DISTRIBUTION; ANTIBODIES, VIRAL; CHILD; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MEXICAN AMERICANS; MIDDLE AGED; MUMPS; MUMPS VIRUS; SEROEPIDEMIOLOGIC STUDIES; UNITED STATES; YOUNG ADULT;

EID: 77955669083     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655394     Document Type: Article

References (39)

1. World Health Organization. Mumps virus vaccines. Wkly Epidemiol Rec 2007; 82:51-60.
2. Centers for Disease Control and Prevention. Recommendation of the Public Health Service Advisory Committee on Immunization Practices: mumps vaccine. MMWR Morb Mortal Wkly Rep 1977; 26:393-394.
3. Centers for Disease Control and Prevention. Summary of notifiable diseases- United States, 2000. MMWR Morb Mortal Wkly Rep 2002; 49: 1-102.
4. Ryan C, SchoberS, Turczyn K. Operational definitions for year 2000 objectives: priority area 20, immunization and infectious diseases. Healthy People 2000 Stat Notes 1997; 11:1-15.
5. Department of Health and Human Services. Healthy People 2010: with understanding and improving health (2 vols). 2nd ed. Washington, DC: Government Printing Office, November 2000.
6. Centers for Disease Control and Prevention. Notifiable diseases/deaths in selected cities weekly information.MMWRCDC Surveill Summ2006; 55:316-327.
7. Dayan GH, Quinlisk MP, Parker AA, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-1589.
8. National Center for Health Statistics. NHANES 1999-2004. http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm. Accessed 3 December 2009.
9. Bureau of the Census. Poverty in the United States: 1990. In: Bureau of the Census, ed. Series P-60. No. 175. Current population reports. Washington, DC: Government Printing Office, 1991.
10. Mohadjer L, MontaquilaJ, Waksberg J. National Health and Nutrition Examination Survey III: weighting and examination methodology- prepared for the National Center for Health Statistics, Hyattsville, MD. Gaitherburg, MD: Westat, 1996.
11. Research Triangle Institute. SUDAAN user's manual release 9.0.1 and 10.1. Research Triangle Park, North Carolina: Research Triangle Institute, 2005.
12. Korn LK, Graubard BI. Confidence intervals for proportions with small expected number of positive counts estimated from survey data. Surv Methodol 1998; 24:193-201.
13. Centers for Disease Control and Prevention. Mumps outbreak-New York, New Jersey, Quebec, 2009. MMWR Morb Mortal Wkly Rep 2009; 58:1-4.
14. Fine PE. Herd immunity: history, theory, practice. Epidemiol Rev 1993; 15:265-302.
15. Anderson RM, Crombie JA, Grenfell BT. The epidemiology of mumps in the UK: a preliminary study of virus transmission, herd immunity and the potential impact of immunization. Epidemiol Infect 1987; 99: 65-84.
16. Anderson RM. The concept of herd immunity and the design of community- based immunization programmes. Vaccine 1992; 10:928-935.
17. Christenson B, Bottiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the mumps virus. Biologicals 1990; 18:213-219.
18. Eick AA, Hu Z,Wang Z, Nevin RL. Incidence of mumps and immunity to measles, mumps and rubella among US military recruits, 2000-2004. Vaccine 2008; 26:494-501.
19. Date AA, Kyaw MH, Rue AM, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis 2008; 197:1662-1668.
20. Dykewicz CA, Kruszon-Moran D, McQuillan GM, et al. Rubella seropositivity in the United States, 1988-1994. Clin Infect Dis 2001; 33: 1279-1286.
21. McQuillan GM, Kruszon-Moran D, Hyde TB, Forghani B, Bellini W, Dayan GH. Seroprevalence of measles antibody in the US population, 1999-2004. J Infect Dis 2007; 196:1459-1464.
22. Centers for Disease Control and Prevention. Mumps vaccine: recommendations of the Public Health Service Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1967; 16: 430-431.
23. Centers for Disease Control and Prevention. Mumps vaccine: recommendations of the Public Health Service Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep 1968; 17: 419.
24. Cochi SL, Preblud SR, Orenstein WA. Perspectives on the relative resurgence of mumps in the United States. Am J Dis Child 1988; 142: 499-507.
25. Atkinson WL, Orenstein WA, Krugman S. The resurgence of measles in the United States, 1989-1990. Annu Rev Med 1992; 43:451-463.
26. Centers for Disease Control and Prevention. Measles prevention: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mortal Wkly Rep 1989; 38(suppl 9):1-18.
27. Centers for Disease Control and Prevention. Mumps surveillance, January 1977-1982. Atlanta, Georgia: Public Health Service, September 1984.
28. Smith PJ, Singleton JA. Vaccination coverage estimates for selected counties: achievement of Healthy People 2010 goals and association with indices of access to care, economic conditions, and demographic composition. Public Health Rep 2008; 123:155-172.
29. Dominguez SR, Parrott JS, Lauderdale DS, Daum RS. On-time immunization rates among children who enter Chicago public schools. Pediatrics 2004; 114:e741-e747.
30. Wooten KG, Luman ET, Barker LE. Socioeconomic factors and persistent racial disparities in childhood vaccination. Am J Health Behav 2007; 31:434-445.
31. Mossong J, Bonert C, Weicherding P, et al. Mumps outbreak among the military in Luxembourg in 2008: epidemiology and evaluation of control measures. Euro Surveill 2009; 14:pii19121.
32. Meyer MB. An epidemiologic study of mumps; its spread in schools and families. Am J Hyg 1962; 75:259-281.
33. Ortuondo EM, Sancristobal IG, Soria LL, Mayo JEE, de Castro Laiz V, Agirre NM. Outbreak of viral parotiditis in a school in Bizkaia, Spain, in 2006 [in Spanish]. Rev Esp Salud Publica 2007; 81:33-42.
34. Mackenzie DG, Craig G, Hallam NF, Moore J, Stevenson J. Mumps in a boarding school: description of an outbreak and control measures. Br J Gen Pract 2006; 56:526-529.
35. Kuhlman JC. Mumps outbreak aboard the USS Reuben James. Mil Med 1994; 159:255-257.
36. Hyde TB, Kruszon-Moran D, McQuillan GM, Cossen C, Forghani B, Reef SE. Rubella immunity levels in the United States population: has the threshold of viral elimination been reached? Clin Infect Dis 2006; 43(suppl 3):S146-S150.
37. Huang AS, Cortese MM, Curns AT, et al. Risk factors for mumps at a university with a large mumps outbreak. Public Health Rep 2009; 124:419-426.
38. Centers for Disease Control and Prevention. Measles, mumps, and rubella: vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps-recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1998; 47(RR-8):1-57.
39. Centers for Disease Control and Prevention. Notice to readers: updated recommendations of the Advisory Committee on Immunization Practices (ACIP) for the control and elimination of mumps.MMWR Morb Mortal Wkly Rep 2006; 55(22):629-630